NEW: Pfizer asks FDA to authorize COVID booster for children 5 to 11
A child receives a dose of the Pfizer-BioNTech COVID-19 vaccine at an elementary school vaccination site for children ages 5 to 11 in Miami, Florida on Nov. 22, 2021.
Photo: Eva Marie Uzcategui/Bloomberg via Getty Imagesfor children ages 5 through 11.If approved, it would be the first booster accessible to children of this age group, who have been hit hard in recent months. Infections rose most sharply among children and adolescents during the Omicron surge,
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Pfizer requests FDA authorization for Covid-19 booster for kids 5 through 11Pfizer and BioNTech said Tuesday that they have submitted an application to the US Food and Drug Administration for emergency use authorization of a booster dose of Covid-19 vaccine for children 5 through 11.
Leer más »
Pfizer Asks FDA to Authorize Third Dose for Children 5 to 11 Years OldPfizer on Tuesday asked the Food and Drug Administration to authorize a third dose of its COVID vaccine for children ages 5- to 11-years-old. The application comes after Pfizer released data earlier this month from a small lab study of blood samples from 30 kids in the age group, which showed a 36-fold increase in antibody levels against the omicron variant…
Leer más »
FDA approves COVID drug for children, China deals with uphill COVID battle, and more COVID newsThe US Food and Drug Administration announced Monday that it has expanded approval of the COVID-19 drug remdesivir to treat patients as young as 28 days old. Here's that and more COVID news.
Leer más »
Biden announces efforts to improve access to Pfizer COVID-19 treatmentThe Biden administration said it will attempt to save more lives with Pfizer’s effective treatment for COVID-19 by nearly doubling the number of pharmacies that stock the pills and setting up federally supported “test-to-treat” sites that offer the drug to people who test positive.
Leer más »
FDA approves Remdesivir to treat COVID in young childrenThe antiviral drug is given as an injection. It was previously approved for patients 12 years of age and older.
Leer más »
FDA approves Remdesivir to treat COVID in young childrenThe antiviral drug is given as an injection. It was previously approved for patients 12 years of age and older.
Leer más »